These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9427776

  • 1. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
    Recchia F, Sica G, De Filippis S, Rea S, Frati L.
    Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 3. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y.
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
    [Abstract] [Full Text] [Related]

  • 4. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
    Hayashi Y, Kato M, Matsuura T, Yamada Y, Adachi S, Ito G, Yamamoto K, Takeuchi T.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE.
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
    Nakabayashi T, Miyamoto H, Fujikane T, Shimizu T, Yasuda S, Akita H, Sakai E, Onodera S, Ohsaki Y, Kawakami Y.
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):61-7. PubMed ID: 1309633
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.
    Oncol Rep; 2002 Jan; 9(3):661-70. PubMed ID: 11956647
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Current results of chemotherapy in non-small cell lung cancer].
    Fukuoka M, Negoro S, Takada M, Matsui K, Takifuji N, Masuda N, Kawahara M, Furuse K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):203-9. PubMed ID: 2162439
    [Abstract] [Full Text] [Related]

  • 14. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
    Itami S, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Fukutani H, Tabata M, Hirano A, Mizunuma N, Nakagawa K.
    Gan To Kagaku Ryoho; 1990 May; 17(5):1015-20. PubMed ID: 2159265
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
    Cigolari S, Curcio C, Maiorino A, Sessa R, Cioffi A, Massimo M.
    Anticancer Res; 2003 Aug; 23(2C):1803-9. PubMed ID: 12820462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
    Kleisbauer JP, Thomas P, Perol M, Taytard A, Poirier R, Collus MJ, Guerin JC, Vergnenegre A, Balmes P, Carles P.
    Rev Mal Respir; 1993 Aug; 10(4):307-12. PubMed ID: 7694331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.